Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome

BACKGROUND: Immune checkpoint inhibitors (ICIs) as a cancer immunotherapy have emerged as a treatment for multiple advanced cancer types. Because of enhanced immune responses, immune-related adverse events (irAEs), including endocrinopathies such as hypophysitis, have been associated with the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanie, Keitaro, Iguchi, Genzo, Bando, Hironori, Urai, Shin, Shichi, Hiroki, Fujita, Yasunori, Matsumoto, Ryusaku, Suda, Kentaro, Yamamoto, Masaaki, Fukuoka, Hidenori, Ogawa, Wataru, Takahashi, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571153/
https://www.ncbi.nlm.nih.gov/pubmed/33977343
http://dx.doi.org/10.1007/s00262-021-02955-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571153/
https://www.ncbi.nlm.nih.gov/pubmed/33977343
http://dx.doi.org/10.1007/s00262-021-02955-y

Ejemplares similares